Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease.
MacDonald, T J
Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. [electronic resource] - Nature genetics Oct 2001 - 143-52 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1061-4036
10.1038/ng731 doi
Butadienes--pharmacology
Enzyme Activation
Enzyme Inhibitors--pharmacology
Gene Expression Profiling
Humans
Immunohistochemistry
MAP Kinase Signaling System
Medulloblastoma--genetics
Mitogen-Activated Protein Kinases--antagonists & inhibitors
Neoplasm Metastasis
Nitriles--pharmacology
Phenotype
Receptor, Platelet-Derived Growth Factor alpha--genetics
Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease. [electronic resource] - Nature genetics Oct 2001 - 143-52 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1061-4036
10.1038/ng731 doi
Butadienes--pharmacology
Enzyme Activation
Enzyme Inhibitors--pharmacology
Gene Expression Profiling
Humans
Immunohistochemistry
MAP Kinase Signaling System
Medulloblastoma--genetics
Mitogen-Activated Protein Kinases--antagonists & inhibitors
Neoplasm Metastasis
Nitriles--pharmacology
Phenotype
Receptor, Platelet-Derived Growth Factor alpha--genetics